BLBannakij Lojanapiwat

Bannakij Lojanapiwat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bannakij Lojanapiwat has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • C Pripathanont

    Chiangmai University; Prince Songkla University; Chulalongkorn University; Mahidol University; Mahidol University, Thailand

    1 shared publication
  • C. Nisoog

    Chaing Mai University, Thailand

    1 shared publication
  • J. Jun-Ou

    Chiangmai University Department of Surgery Division of Urology

    1 shared publication
  • K Lertwuttichaikul

    Division of Urology, Maharat Nakornratchasima Hospital, Nakornratchasima, Thailand

    1 shared publication
  • M Tanthanuch

    Chiangmai University; Prince Songkla University; Chulalongkorn University; Mahidol University; Mahidol University, Thailand

    1 shared publication
  • N Suparatchatpan

    Division of Urology, Maharat Nakornratchasima Hospital, Nakornratchasima, Thailand

    1 shared publication

Latest Publications

  • Open Access

    Efficacy and safety of percutaneous nephrolithotomy (PCNL): a prospective and randomized study comparing regional epidural anesthesia with general anesthesia

    by T. Tangpaitoon, C. Nisoog, B. Lojanapiwat

    To compare the efficacy and safety of regional epidural anesthesia and general anesthesia in patients who underwent PCNL. Fifty patients submitted to percutaneous nephrolithotomy (PCNL) were randomized into two groups: Group I (N = 26) received general anesthesia and Group II (N = 24) received regional epidural anesthesia. Demographic and operative data including age, BMI, stone position, stone size, postoperative pain, amount of postoperative analgesic usage, length of hospital stay, patient satisfaction, preoperative and postoperative hemoglobin and hematocrit, adverse effects and surgical complications were compared between both groups. Average pain score at 1 hour. was 6.88 in group I and 3.12 in group II (p < 0.001), at 4 hours. 5.07 in group I and 3.42 in group II (p = 0.025). Less morphine was required in the regional epidural anesthesia group compared to the general anesthesia group. Higher satisfaction was found in the regional epidural group. 6 (23.07 %) patients in Group I and 1 patient (4.19 %) in Group II had postoperative nausea and vomiting, respectively (p = 0.05). Pain score at 12 hours, 24 hours, 48 hours, 72 hours, preoperative and postoperative hemoglobin and hematocrit, length of hospital stay, and adverse effects were no different between the two groups. Regional epidural anesthesia is an alternative technique for PCNL which achieves more patient satisfaction, less early postoperative pain and less adverse effects from medication with the same efficacy and safety compared to general anesthesia.


  • Open Access

    Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy

    by B Lojanapiwat, M Tanthanuch, C Pripathanont, S Ratchanon, S Srinualnad, T Taweemonkongsap, S Kanyok, S Lammongkolkul

    To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. A total of 76 patients with calcium calculi who were stone-free or had residual stones less than 4 mm following ESWL and PCNL were enrolled. All patients were independently randomized into two groups. The treated group (N = 39) was given 81 mEq per day of oral potassium-sodium citrate (27 mEq three times a day), and the untreated group (N = 37) serving as controls. Blood, twenty-four hour urine analysis, and plain KUB were measured and compared at the baseline and after 12 months. At baseline, hypocitraturia was found in 20 of 39 patients (46.05%) of Group I and 15 of 37 patients (40.5%) of Group II. At 12 months, hypocitraturia was found in 3 of 39 (7.69%) and 14 of 37 (37.83%) of Group I and Group II, respectively (p = 0.007). At the 12 month follow-up, of the stone-free group, 92.3% of the treated group and 57.7% of the control group were still stone free. Of the residual stone group, 30.8% and 9.1% of treated and control group were stone-free, respectively. The increased stone size found in 7.7%) and 54.5%) of treated and control groups, respectively. Sodium-potassium citrate provides positive effects on stone-forming activities in calcium stone patients suffering from urolithiasis following treatment with ESWL and PCNL procedures at the 12-month follow-up.


  • Open Access

    The efficacy and safety of oral Tamsulosin controlled absorption system (OCAS) for the treatment of lower urinary tract symptoms due to bladder outlet obstruction associated with benign prostatic hyperplasia: an open-label preliminary study

    by Bannakij Lojanapiwat, Sompol Permpongkosol

    AIMS: Tamsulosin, a superselective subtype alpha 1a and 1d blocker, is used for the treatment of male lower urinary tract symptoms (LUTS) commonly caused by benign prostatic hyperplasia (BPH). This prospective study evaluated the efficacy and safety of a new formulation, Tamsulosin OCAS® (Oral Controlled Absorption System), for LUTS associated with BPH in Thai patients. MATERIALS AND METHODS: Fifty one patients over 40 years old with complaints of LUTS associated with BPH were recruited. Patients received an 8 week course of once daily 0.4 mg tamsulosin OCAS®, and were followed up at 2 (visit 3), 4 (visit 4) and 8 (visit 5) weeks post-treatment. At each visit, patients were assessed using the International Prostate Symptom Score (IPSS), Nocturia Quality of Life (N-QoL) Questionnaire, QoL Assessment Index (IPSS-QoL), and International Index of Erectile Function (IIEF). The primary outcome was efficacy of Tamsulosin. The secondary outcomes included change in the mean number of nocturia episodes, hours of undisturbed sleep (HUS) and uroflowmetry measurements. RESULTS: Total IPSS significantly decreased at week 8 from baseline (from 19.52 to 6.08; p < 0.001). Similarly, the voiding and storage subscores of IPSS also continued to improve significantly starting from the second and third visits, respectively (p < 0.001 versus baseline). The IPSS-QoL and N-QoL scores significantly improved at visit 3 through end of study. In addition, we observed significant nocturia and HUS improvement in their last clinic visit. Uroflowmetry parameters, Qmax and Qave, improved significantly at 3rd clinic visit . Three patients experienced mild dizziness. CONCLUSION: Tamsulosin OCAS® treatment led to significant improvements in LUTS, HUS and QoL in Thai patients with bladder outlet obstruction from BPH with few side effects.


  • Role of Preoperative and Intraoperative Factors in Mediating Infection Complication following Percutaneous Nephrolithotomy

    by B. Lojanapiwat, P. Kitirattrakarn

    Objective: To identify the pre- and intraoperative factors that affect the development of postoperative systemic inflammatory response syndrome (SIRS) following percutaneous nephrolithotomy (PCNL). Patients and Methods: A total of 200 patients were treated with PCNL, 56 of which developed postoperative SIRS (group I) and 144 did not (group II). For these 2 groups, the patient factor, operative factor, preoperative urine culture, pelvic urine culture, and stone culture were compared. Results: Average age, stone size, operative time, success rate, and number of tubeless PCNL were not significantly different between the 2 groups. However, preoperative urine culture, pelvic urine culture, and stone culture, respectively, were positive in 66.1, 46.4 and 48.2% of the patients in group I, but only 10.4, 3.5 and 3.5% for the corresponding specimens in group II. In addition, 5 patients in group I developed clinical septic shock, 4 of which were positive for all cultures and 1 positive only for stone culture. Conclusion: Infection following PCNL is common, but only a few cases progress to septic shock. Positive preoperative urine, intraoperative pelvic urine and stone cultures are important factors indicating the development of postoperative SIRS. Intraoperative cultures are important for decision-making about the treatment of postoperative infection complications.


  • Open Access

    Supracostal access: does it affect tubeless percutaneous nephrolithotomy efficacy and safety?

    by J. Jun-Ou, Bannakij Lojanapiwat

    INTRODUCTION: Tubeless percutaneous nephrolithotomy (PCNL) in selected patients has been found to be safe and can reduce postoperative discomfort without increasing complications. The challenges of tubeless PCNL via supracostal access are inadequate drainage and postoperative bleeding, conditions that may increase pulmonary complications. We compare the efficacy and safety of the tubeless supracostal versus the standard supracostal PCNL. MATERIALS AND METHODS: Supracostal PCNL with one percutaneous renal access, no significant bleeding, extravasation and residual stone was performed in 95 patients. Of these, 43 were tubeless PCNL (Group-I) and 52 were PCNL with standard routine postoperative nephrostomy tube (Group-II). In group-I, PCNL was done by the standard supracostal technique with the placement of a postoperative external ureteral catheter for 48 hours. The operative time, success rate, hospital stay and ensuing complications were compared between group-I and group-II. RESULTS: Patients in the tubeless PCNL group (Group-I) were 90.7% stone -free while those with standard routine postoperative nephrostomy tube(Group-II) were 84.6% stone -free. Additionally, stone fragments of less than 4 mm in diameter were found in 9.3% of patients in group-I and 25.4% in group-II. The success rate, hematocrit change and complication were not significantly different between both groups. The analgesic requirement, operative time and hospital stay were all significantly less in the tubeless supracostal group (Group-I). None of group I and only one patient of group II needed intercostal drainage. CONCLUSION: Tubeless supracostal percutaneous nephrolithotomy in selected patients is effective with acceptable complications. This technique offers the advantage of lower analgesic requirement, shorter operative time and hospital stay. The pulmonary complication is the same as the standard supracostal percutaneous nephrolithotomy.


  • Effectiveness of Low-dose and Standard-dose Tamsulosin in the Treatment of Distal Ureteric Stones: A Randomized Controlled Study

    by B Lojanapiwat, W Kochakarn, N Suparatchatpan, K Lertwuttichaikul

    Low-dose (0.2 mg/day) and standard-dose (0.4 mg/day) tamsulosin were studied in a randomized controlled trial of 75 outpatients with distal ureteroliths in Thailand. Group 1 ( n = 25; control) received oral sodium diclofenac 50 mg twice a day for 10 days; group 2 ( n = 25) received oral sodium diclofenac 50 mg twice a day for 10 days, with oral tamsulosin 0.2 mg once a day up to 28 days; and group 3 ( n = 25) received oral sodium diclofenac 50 mg twice a day for 10 days, with oral tamsulosin 0.4 mg once a day up to 28 days. For groups 1, 2 and 3, respectively, the expulsion rates were 4%, 40% and 68% (significantly different for group 1 vs group 2, and for group 1 vs group 3) and mean expulsion times were 23.00, 9.30 and 10.76 days. Both doses of tamsulosin increased stone expulsion rate and decreased expulsion time in comparison with the control, and have been shown to be safe and effective in Asian patients.


  • Colonization of internal ureteral stent and bacteriuria

    by B. Lojanapiwat

    To demonstrate the infection rates, colonization rates following the internal ureteral stent placement; the correlation of indwelling time with the infection, bacterial colonization and the value of urine culture to identify colonizing bacteria One hundred and forty-eight stents of 146 patients were evaluated for the bacteriuria and colonization after internal ureteral placement average 8.6 weeks according to the indication. All patients were ambulatory and were examined in an outpatient clinic. Urine culture and 1 cm of proximal and distal ends was taken for culture for bacterial evaluation. The rate of colonization is 33, 50 and 54% when indwelling time is less than 4 weeks, 4–6 weeks and more than 6 weeks, respectively. Urine culture can detect colonization in 69%. Colonization was not found if the indwelling time was less than 2 weeks. Escherichia coli, Enterobacter and Pseudomonas spp. were the most common colonized organisms. Colonization is common if the indwelling time is more than 2 weeks, urine culture can detect colonization in about two to three of the patients. Even if the culture is negative, prophylactic antibiotic that cover gram-negative and gram-positive organisms should be administrated when the patients require further procedures.


  • Upper-Pole Access for Percutaneous Nephrolithotomy: Comparison of Supracostal and Infracostal Approaches

    by B. Lojanapiwat, S. Prasopsuk

    The advantage of upper-pole access for nephrolithotomy is direct access to most of the intrarenal collecting system and upper ureter. Upper-pole access can be achieved either supracostally and subcostally. Because of the anatomic location of the kidneys, the supracostal approach is associated with a higher rate of pulmonary complications. We compared the efficacy and safety of the supracostal and infracostal upper-pole approaches. A total 464 patients were treated with percutaneous nephrolithotomy (PCNL) via the upper pole, of which 170 punctures (group I) were performed supracostally and 294 (group II) subcostally. In both groups, PCNL was done by the standard technique with fluoroscopic guidance. The operative time, success rate, hospital stay, and complications in the two groups were compared. Patients were stone free in 82.2% and 77.1% of the cases in groups I and II, respectively, and had stone fragments <4 mm in 10.7% and 14.7%, respectively. The operative time, success rate, and septic and hemorrhagic complications were not significantly different in the two groups. Hydrothorax was found in 26 patients (15.3%) of group I and 4 (1.4%) of group II. Only 9 patients (5.3%) in group I needed intercostal drainage. Percutaneous nephrolithotomy via the upper pole is effective using both supracostal and infracostal approaches, with acceptable rates of complications. The rate of pulmonary complications is higher with the supracostal approach. If the supracostal approach is indicated, it should be used with caution.


  • Previous Open Nephrolithotomy: Does It Affect Percutaneous Nephrolithotomy Techniques and Outcome?

    by B. Lojanapiwat

    The consequences of open nephrolithotomy are scar tissue around the kidney and in the retroperitoneum and distortion of the pelvicaliceal anatomy that may affect the techniques and outcome of percutaneous nephrolithotomy (PCNL). We compared the results and complications of patients undergoing PCNL who had and had not previously undergone open nephrolithotomy. A total of 178 calculi in 175 patients who had previously had open nephrolithotomy (group I) and 178 calculi in 175 patients who had never had a renal operation (group II) were treated with PCNL. The average time between open nephrolithotomy and PCNL was 8.5 years (range 4 months-22 years). In both groups, PCNL was done by a standard technique with serial Amplatz dilator enlargement of the tract to 30F. Upper-pole access under fluoroscopic guidance was done in most patients. The operative time, success rate, hospital stay, and complications in the two groups were compared. The stone-free rates were 80.3% and 82.6% in groups I and II, respectively, and the rate of residual fragments < or =4 mm was 14.6% and 8.4%. The operative time, success rate, hospital stay, and complications did not differ significantly in the two groups. Percutaneous nephrolithotomy is effective and safe in patients who have previously had open nephrolithotomy with no more complications than are seen with PCNL of kidneys that have not been operated on.


    • 1 September 2005
      • Vol. 88  (9) , 1203-6

    Endourologic management of severely encrusted ureteral stents.

    by Bannakij Lojanapiwat

    Ureteral stents are in common use in urologic practice. Even though the stent is a valuable urological tool, its use has two widely encountered complications, namely, stent encrustation and stone formation. These complications are difficult to manage; but endourologic surgery, which is minimally invasive, has become the first choice in the treatment for encrustation and stone formation. Eight patients with severely encrusted ureteral stents were treated by endourologic techniques. One patient had severe encrustation at all sites of the stent and was treated by percutaneuos nephrolithotomy, ureteroscopy with intracorporeal lithotripsy and cystolitholapaxy. Five patients with severe encrustation at both ends of the stent were treated with percutaneous nephrolithotomy and cystolitholapaxy (4 cases) and with extracorporeal shock wave lithotripsy (ESWL) and cystolitholapaxy. The last two patients with severely encrusted ureteral stents at the bladder end were treated with percutaneous cystolithotomy with intracorporeal lithotripsy and by optical lithotrite, respectively. All cases were stone free and stent free in one session without complication. The average approaches were 1.9 (range 1-3). All stents were removed intact and no subsequent stent was required following the removal of the problematic stent. Endourologic surgery which is minimally invasive surgery, is the first choice of treatment for the management of severely encrusted ureteral stents with good results in one session without complications and no subsequent stent is necessary. The authors recommend removing the stent as soon as possible or change the new stent every 3 months for decreasing the incidence of these complications.